{"id":162335,"date":"2025-06-30T00:00:00","date_gmt":"2025-06-30T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2025\/06\/30\/triglyceride-glucose-index-may-predict-faster-cognitive-decline-in-early-phases-of-alzheimer-disease\/"},"modified":"2025-07-01T16:10:13","modified_gmt":"2025-07-01T16:10:13","slug":"triglyceride-glucose-index-may-predict-faster-cognitive-decline-in-early-phases-of-alzheimer-disease","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2025\/06\/30\/triglyceride-glucose-index-may-predict-faster-cognitive-decline-in-early-phases-of-alzheimer-disease\/","title":{"rendered":"Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease"},"content":{"rendered":"<h3>\n<p>High triglyceride-glucose index significantly associated with faster cognitive decline in the MCI-Alzheimer disease subgroup<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><br \/>\n<b><\/b><\/p>\n<p>MONDAY, June 30, 2025 (HealthDay News) &#8212; For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the triglyceride-glucose (TyG) index experience faster cognitive decline, according to a study presented at the 11th Congress of the European Academy of Neurology, held from June 21 to 24 in Helsinki.<\/p>\n<p>Bianca Gumina, M.D., from the University of&nbsp;Brescia in Italy, and colleagues  conducted a retrospective study to examine insulin resistance (using TyG as a surrogate marker for insulin resistance) as a progression marker in patients with a cerebral spinal fluid-based diagnosis of AD or other neurodegenerative diseases (NDDs) who were nondiabetic. Patients were stratified into tertiles according to TyG index (low, medium, high). A total of 315 patients entered the study: 210 with AD and 115 with other NDDs.<\/p>\n<p>The researchers found that high TyG index was linked to worse blood-brain-barrier markers in AD and interacted with <em>APOE<\/em> \u03b54, with no effect seen in other NDDs. More cardiovascular risk factors were exhibited in patients with AD with high TyG index, while baseline characteristics were similar. In the MCI-AD subgroup (161 patients), high TyG index was significantly associated with faster cognitive decline over three years of follow-up (hazard ratio, 4.08). For MCI-to-dementia conversion, there was a similar but nonsignificant trend observed. For progression, there was no significant TyG index-<em>APOE<\/em> interaction. In the other NDDs group, TyG index showed no impact on clinical progression.<\/p>\n<p>&#8220;We were surprised to see the effect only in the Alzheimer&#8217;s spectrum and not in other neurodegenerative diseases,&#8221; Gumina said in a statement. &#8220;It suggests a disease-specific vulnerability to metabolic stress during the prodromal window, when interventions may still change the trajectory.&#8221;<\/p>\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.70189\">Abstract No. OPR-066<\/a><\/p>\n<p><a href=\"https:\/\/www.ean.org\/congress2025\">More Information<\/a><\/p>\n<p><i><\/i><br \/>\n<i>Copyright &#169; 2025 <a href=\"https:\/\/consumer.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>High triglyceride-glucose index significantly associated with faster cognitive decline in the MCI-Alzheimer disease subgroup<\/p>\n","protected":false},"author":6,"featured_media":162842,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-162335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/162335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=162335"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/162335\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/162842"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=162335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=162335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=162335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}